Skip to main content
search
Fact Sheet

Expedited Pharmacometrics Regulatory Submissions

Connect with Certara

Connect with a Certara pharmacometrics consultant to discuss your regulatory objectives and map out an accelerated PMx plan.

Learn more

You May Also Like

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema
Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary AngioedemaPublication

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Supporting KalVista’s NDA Submission for a Novel HAE Treatment​
Supporting KalVista’s NDA Submission for a Novel HAE Treatment​Case Study

Supporting KalVista’s NDA Submission for a Novel HAE Treatment​

Supporting Ionis’ Donidalorsen BLA with Biomarker​ HAE Attack Rate Modeling
Supporting Ionis’ Donidalorsen BLA with Biomarker​ HAE Attack Rate ModelingCase Study

Supporting Ionis’ Donidalorsen BLA with Biomarker​ HAE Attack Rate Modeling